Proteomics: Technologies and Global Markets

Report Code: BIO034G

Publish Date: May 2025

Publisher: BCC Publishing

Category: Cell Biology

Download Report OverviewTARIFF UPDATE

Limited Period Offer

CUSTOMIZE NOW

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.

Report Includes

  • 97 data tables and 56 additional tables
  • An overview of the global markets for proteomics and related technologies
  • Analyses of the global market trends, with historic market revenue data from 2022 to 2024, estimates for 2025 and projected CAGRs through 2030
  • Estimates of the actual market size and forecasts for proteomics, and a corresponding market share analysis by platform type, application, product type, and region
  • In-depth facts and figures concerning market dynamics, technology advances, new products and applications for proteomics
  • Discussion of patents and emerging technologies
  • ESG trends in the industry
  • Insight into the industry structure for proteomics technologies, competitive aspects of each product segment, companies’ growth strategies, and a company value share analysis
  • Updated information on mergers and acquisitions, agreements, partnerships and new products in the global proteomics industry
  • Profiles of the leading companies, including Thermo Fisher Scientific Inc., Danaher, Agilent Technologies Inc., Bruker and Waters Corp.

Report Scope

The report analyzes trends in the global market for proteomic technologies market. It includes global revenues ($ millions) for the base year of 2024, estimates for 2025 and forecasts for 2025 through 2030. The market is segmented by product type, application, platform and region. Protein structural analysis and protein-expression products are outside the scope of the report. Product types include instruments and software, and consumables. Platforms include mass spectrometry and biochip. Applications include drug discovery and development, research, diagnostics, and applied proteomics. Regions are North America, Europe, Asia-Pacific and the Rest of the World (RoW). North America includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea and the Rest of Asia-Pacific. RoW includes the Middle East and Africa (MEA) and South America.

The report focuses on the trends and challenges that affect the market and vendor landscape. It discusses emerging technologies and includes an analysis of the market shares of the leading companies. It offers a chapter on environmental, social, and corporate governance (ESG) developments. Its section on company profiles covers details such as financials, product portfolio, and recent developments.

Report Synopsis

Report Metrics Details
Base year considered 2024
Forecast period considered 2025-2030
Base year market size $27.6 Billion
Market size forecast $57.2 Billion
Growth rate CAGR of 13.0% from 2025 to 2030
Units considered $ Millions
Segments covered By Platform, Application, Product Type and Region
Regions covered North America, Europe, Asia-Pacific and the Rest of the World (RoW)
Countries covered U.S., Canada, Mexico, Germany, the U.K., Italy, France, Spain, Japan, China, India, South Korea, Rest of Asia-Pacific, and Rest of Europe
Key Market Drivers
  • Increasing investments in R&D.
  • Transition towards personalized medicine.
  • Rising aging population and growing prevalence of chronic diseases.
  • Emerging technologies.
Companies studied
AGILENT TECHNOLOGIES INC.ARRAYIT CORP.
BIO-RAD LABORATORIES INC.BIO-TECHNE
BRUKERCREATIVE PROTEOMICS
DANAHER CORP.JEOL LTD.
MERCK KGAAPROMEGA CORP.
REVVITYSHIMADZU CORP.
STANDARD BIOTOOLSTHERMO FISHER SCIENTIFIC INC.
WATERS CORP.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS

Frequently Asked Questions (FAQs)

The global proteomics market is valued at $27.6 billion in 2024 and is expected to grow at a CAGR of 13% to reach $57.2 billion by 2030.
The global market of proteomic technologies is growing due to the rising aging population and growing prevalence of chronic diseases, increasing investments in research and development activities, increasing investment in the biotechnology sector, and rising demand for personalized medicine.
The global market for proteomic technologies is segmented based on platform, product type, application, and region.
The mass spectrometry segment will dominate the market in 2030.
North America holds the highest share of the market.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Proteomics: Technologies and Global Markets153Free
Chapter- 1: Executive Summary5Free
Chapter- 2: Market Overview6Free
Chapter- 3: Market Dynamics8Free
Chapter- 4: Regulatory Landscape2Free
Chapter- 5: Emerging Technologies and Developments8Free
Chapter- 6: Market Segmentation Analysis56Free
Chapter- 7: Competitive Intelligence6Free
Chapter- 8: Sustainability in the Proteomics Technology Industry: ESG Perspective5Free
Chapter- 9: Appendix57Free
Published - Jan-2023| Analyst - BCC Publishing| Code - BIO034F

Report Highlights

The global proteomics market should reach $55.1 billion by 2027 from $27.1 billion in 2022 at a compound annual growth rate (CAGR) of 15.3% for the forecast period of 2022 to 2027.

Report Includes

  • 149 data tables and 97 additional tables
  • An up-to-date overview of the global markets for proteomics and related technologies
  • Analyses of the global market trends, with historic market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the upcoming market potential for the global proteomics industry, growth driving factors, and areas of focus to forecast this market into various segments and sub-segments
  • Estimation of the actual market size and market forecast for proteomics in value (USD millions) terms, and their corresponding market share analysis by platform technology, end-user application, and region
  • In-depth information (facts and figures) concerning major market dynamics (DROs), technology advancements, new products and applications in proteomics, and COVID-19 impact on the market for proteomics
  • Insight into recent industry structure for proteomics technologies, competitive aspects of each product segments, major growth strategies, and company value share analysis based on their segmental revenues
  • Updated information on key mergers and acquisition deals, agreements, partnerships, collaborations and product launches within the global proteomics industry
  • Profile descriptions of the leading proteomics manufacturers, including Agilent, Danaher Corp., GlaxoSmithKline PLC, PerkinElmer Inc., Qiagen GmbH, and Sanofi.
Published - Oct-2018| Analyst - Bhavna Joshi| Code - BIO034E

Report Highlights

The global market for proteomics should grow from $7.9 billion in 2017 to $16.8 billion by 2022 at a compound annual growth rate (CAGR) of 16.2% for the period of 2017-2022.

Report Includes

  • 20 data tables and 62 additional tables
  • An overview of the global proteomics market, which covers: technologies, platform and software markets, disease markets, biochip markets and end-use industry markets
  • Analyses of global market trends, with data from 2016 and 2017, and projections of CAGRs through 2022
  • Examination of market trends and opportunities that will impact the future market
  • A look at proteomics scientific initiatives, industry acquisitions and patents
  • Discussion of proteomic applications in drug discovery and development
  • Comprehensive company profiles across subsegments, such as protein chip providers, reagent providers, service providers, informatics and database providers, etc.
  • Company profiles of major players, including Abcodia Ltd., Bruker Corp., Digilab Inc., Glaxosmithkline Plc., & Luminex Corp.
Published - Feb-2015| Analyst - John Bergin| Code - BIO034D

Report Highlights

The global proteomics market was valued at nearly $5.1 billion in 2014 and is growing at a compound annual growth rate (CAGR) of 18.0% to reach a forecast value of $11.6 billion by 2019.

Report Includes

  • An overview of the global proteomics market, which covers: technologies, database and software markets, equipment markets, application markets and service markets.
  • Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.
  • Discussion of trends and opportunities, top-selling products, key players, and a competitive outlook.
  • Comprehensive company profiles across subsegments, such as protein chip providers, reagent providers, service providers, informatics and database providers, etc.
Published - May-2013| Analyst - John Bergin| Code - BIO034C

Report Highlights

The global proteomic market was worth nearly $3.7 billion in 2011 and nearly $4.2 billion in 2012, and is forecast to grow at a compound annual growth rate (CAGR) of 16.1% during the next five years to reach nearly $8.9 billion in 2017.

Report Includes

  • An overview of the global proteomics market, which covers: technologies, database and software markets, equipment markets, application markets and service markets.
  • Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017.
  • Discussion of trends and opportunities, top-selling products, key players, and a competitive outlook.
  • Comprehensive company profiles across subsegments, such as protein chip providers, reagent providers, service providers, informatics and database providers, etc.
Published - Jun-2009| Analyst - Sathya Durga| Code - BIO034B

Report Highlights

  • The global market for proteomics is expected to increase from $6.7 billion in 2008 to an estimated $7.9 billion in 2009 and $19.4 billion in 2014, for a compound annual growth rate (CAGR) of 19.7%.
  • Proteomics equipment was valued at $4.1 billion in 2008 and an estimated $4.8 billion in 2009. This is expected to increase to $13.0 billion in 2014, for a CAGR of 22%..
  • Proteomics technologies were worth $1.3 billion in 2008 and an estimated $1.5 billion in 2009. This segment is expected to increase at a CAGR of 13.9% to reach $2.9 billion in 2014.
Published - Jan-2002| Analyst - Valarie Natale| Code - BIO034A

Report Highlights

  • Proteomics is an emerging field that has developed in the wake of genomics. Its goal is to understand protein expression at the cellular level, and apply this information to scientific and medical problems. For example, compared to healthy cells, how does influenza virus infection affect the total protein output? Are any of the proteins expressed only in the infected cells suitable targets for new antiviral drugs? This approach also applies to cancerous cells, and cells from patients with degenerative diseases and many other conditions. New technologies like protein chips and capillary electrophoresis are emerging to serve proteomic studies, and more mature technologies like 2-D electrophoresis, mass spectroscopy, and nuclear magnetic resonance spectroscopy are being adapted for protein studies, and in some cases, for high throughput uses. Bioinformatics applications are constantly being developed to analyze the data produced by all of these technologies.
  • This BCC study examines how proteomics technologies have affected basic research and pharmaceutical research, and how they are likely to affect research in the near future. It also analyzes how proteomics technologies are developing, and examines new companies that are likely to make substantial contributions to the field. An important part of the report analyzes instruments that are vital to proteomics studies. Sales and spending projections through 2006 are included.

Related Reports

Single-Cell Genomics and Proteomics: Emerging Technologies and Markets

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO143C

The global market for single-cell genomics and proteomics is expected to grow from $4.0 billion in 2024 to reach $9.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 17.6% from 2024 through 2029.

Global Multiomics Market

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO260A

The global market for multiomics is expected to grow from $2.7 billion in 2024 and is projected to reach $5.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.5% during the forecast period of 2024 to 2029.

Global Spatial Genomics and Transcriptomics Market

Published - Apr 2023 | Publisher - BCC Publishing | Code - BIO239A

The global market for spatial genomics and transcriptomics is estimated to increase from $1.5 billion in 2022 to reach $2.5 billion by 2027, at a compound annual growth rate (CAGR) of 10.8% from 2022 through 2027.

Sample Preparation in Genomics, Proteomics, and Epigenomics: Global Markets

Published - Apr 2023 | Publisher - BCC Publishing | Code - BIO089E

The global sample preparation in genomics, proteomics, and epigenomics market should reach $7.4 billion by 2027 from $5.4 billion in 2022 at a compound annual growth rate (CAGR) of 6.4% for the forecast period of 2022 to 2027.

Recent Reports

Proteomics: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO034G

The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.

Biologic Therapeutic Drugs: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO079F

The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.

Global Markets and Manufacturing Technologies for Protein Drugs

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO021G

The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.

G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Global Markets

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO136B

The global G protein-coupled receptor (GPCR) market is expected to grow from $4.4 billion in 2024 and is projected to reach $6.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.

2024 Cell and Gene: Research Review

Published - Apr 2025 | Publisher - Various Analysts | Code - BIO267A

Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. These Research Reviews include portions of several market research reports that were published in 2024.

Top Trending Reports

Global Markets for Emerging Medical Device Technologies

Published - Mar 2025 | Publisher - BCC Publishing | Code - HLC191C

The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.

Global Diabetic Care Devices Market

Published - Feb 2025 | Publisher - BCC Publishing | Code - MDS019B

The global market for diabetes monitoring devices is expected to grow from $16.6 billion in 2024 to $26.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.1% from 2024 through 2029.

Generative AI: Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - IFT308A

The global market for generative AI was valued at $15.4 billion in 2023. It is projected to grow from $20.8 billion in 2024 to $94.4 billion by 2029, at a compound annual growth rate (CAGR) of 35.3% from 2024 through 2029.

2024 Medical Devices Research Review

Published - Mar 2025 | Publisher - BCC Publishing | Code - MDS060B

The medical device industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years These devices treat and diagnose a multitude of patient conditions and work much better than drugs.

Single-Cell Genomics and Proteomics: Emerging Technologies and Markets

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO143C

The global market for single-cell genomics and proteomics is expected to grow from $4.0 billion in 2024 to reach $9.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 17.6% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Proteomics: Technologies and Global Markets
Sample Report